Open an account

GraniteShares YieldBOOST Biotech ETF

BIOY · ETF

$19.06−$0.2575 (−1.33%)TodayMarket closed ·
Prev close $19.32

About BIOY

BIOY was created on 2026-05-05 by GraniteShares. The fund's investment portfolio concentrates primarily on health care equity. BIOY is an actively managed fund seeking to provide weekly income. The fund strategy involves writing put options on a 3x daily leveraged ETF tied to the S&P Biotechnology Select Industry Index.

Issuer
GraniteShares
Expense ratio
1.07%
Assets under management
$1.55M
Inception
May 5, 2026
Asset class
Equity
Website
graniteshares.com

BIOY key statistics

Price-earnings ratio
0.00
Average volume
2.26K
Volume
1.18K
Open price
$19.02
High today
$19.06
Low today
$18.96
52 Week high
$25.28
52 Week low
$18.89

GraniteShares YieldBOOST Biotech ETF (BIOY) at a glance

GraniteShares YieldBOOST Biotech ETF (BIOY) last traded at $19.06, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $18.96 and $19.06. The current price is 0.5% above the day's low and 0.0% below its high.

Volume so far is 1.18K shares, below the average of 2.26K shares a day.

Over the past year GraniteShares YieldBOOST Biotech ETF has ranged from $18.89 to $25.28, and now sits 3% of the way up that range.

BIOY news

  • Chandrima Sanyal

    Weekly Paycheck From Wall Street? GraniteShares Launches Income ETFs Exposed To Tech, Biotech, Financials, Treasuries

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.